428 related articles for article (PubMed ID: 11506127)
1. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6).
Minoda Y; Kharasch ED
Anesthesiology; 2001 Aug; 95(2):509-14. PubMed ID: 11506127
[TBL] [Abstract][Full Text] [Related]
2. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
3. Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4.
Kharasch ED; Hankins DC; Fenstamaker K; Cox K
Eur J Clin Pharmacol; 2000; 55(11-12):853-9. PubMed ID: 10805064
[TBL] [Abstract][Full Text] [Related]
4. Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes.
Miyazawa M; Gyoubu K
Xenobiotica; 2007 Sep; 37(9):943-53. PubMed ID: 17992728
[TBL] [Abstract][Full Text] [Related]
5. Role of human cytochrome P4502A6 in C-oxidation of nicotine.
Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
Drug Metab Dispos; 1996 Nov; 24(11):1212-7. PubMed ID: 8937855
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 species involved in the metabolism of quinoline.
Reigh G; McMahon H; Ishizaki M; Ohara T; Shimane K; Esumi Y; Green C; Tyson C; Ninomiya S
Carcinogenesis; 1996 Sep; 17(9):1989-96. PubMed ID: 8824525
[TBL] [Abstract][Full Text] [Related]
7. Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms.
Spracklin DK; Kharasch ED
Drug Metab Dispos; 1998 Jun; 26(6):605-7. PubMed ID: 9616199
[No Abstract] [Full Text] [Related]
8. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
Heyn H; White RB; Stevens JC
Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
[TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of (-)-camphor using human liver microsomes and CYP2A6.
Gyoubu K; Miyazawa M
Biol Pharm Bull; 2007 Feb; 30(2):230-3. PubMed ID: 17268056
[TBL] [Abstract][Full Text] [Related]
10. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
Pearce R; Greenway D; Parkinson A
Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
Taavitsainen P; Juvonen R; Pelkonen O
Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
[TBL] [Abstract][Full Text] [Related]
12. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
13. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
14. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
15. Isoflurane acts as an inhibitor of oxidative dehalogenation while acting as an accelerator of reductive dehalogenation of halothane in guinea pig liver microsomes.
Fujii K
Toxicology; 1995 Dec; 104(1-3):123-8. PubMed ID: 8560490
[TBL] [Abstract][Full Text] [Related]
16. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of (+)-terpinen-4-ol by cytochrome P450 enzymes in human liver microsomes.
Haigou R; Miyazawa M
J Oleo Sci; 2012; 61(1):35-43. PubMed ID: 22188805
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
Jacobson PA; Green K; Birnbaum A; Remmel RP
Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
[TBL] [Abstract][Full Text] [Related]
19. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
